FDA Alert: Sitagliptin (marketed as Januvia and Janumet) - acute pancreatitis
Links shared publicly online about this topic.
- 1,720total visits
FDA Alert: Sitagliptin (marketed as Januvia and Janumet) - acute pancreatitis
FDA Alert: Sitagliptin (marketed as Januvia and Janumet) - acute pancreatitis
View full resource at drugs.com
Tags: Diabetes Type 2 Medication, FDA, Januvia
Most Recently Shared on September 26, 2009 at 8:24 pm By:
Did a pt develop hemorrhagic pancreatitis while on Sitagliptin (Januvia)? http://tinyurl.com/yalg925
Also Shared By:
FDA links Januvia to pancreatitis - FiercePharma
fiercepharma.com — “Concerned by post-marketing cases of pancreatitis, FDA is adding the reports to labeling on Merck's (MRK) diabetes drug Januvia (sitagliptin) and a combo form of the drug, Janumet. The agency is... Read more...” View full resource at fiercepharma.com
Most Recently Shared on September 30, 2009 at 6:48 pm By:
RT @safety_alertss: #Drug #PtSafety #FDA links Januvia to pancreatitis Merck's #diabetes medication, new use #labeling. http://ow.ly/rLrk
Advertisement
Patricia Goode
@pgoode
FDA notified healthcare professionals of revisions to include information on reported cases of acute pancreatitis....http://short.to/rthu
1 year ago...